CVS HEALTH CORP
Loading stock data...
Key Financial Metrics (TTM | FY 2025)
$402.07B
Revenue
$1.77B
Net Income
1.40
EPS (Diluted)
$16.72B
Free Cash Flow
Profitability
Gross Margin
44.99%
Operating Margin
1.16%
Net Profit Margin
0.44%
EBITDA
$9.27B
Returns & Efficiency
Return on Assets (ROA)
0.70%
Return on Equity (ROE)
2.35%
Gross Profit
$180.90B
Operating Income
$4.66B
Financial Health
Total Assets
$253.54B
Total Debt
$60.50B
Debt to Equity
2.37x
Current Ratio
0.84
Debt Analysis
Debt to EBITDA
-
Debt to Free Cash Flow
-
Cash & Equivalents
-
Net Debt
-
Capital Returns
Return on Invested Capital (ROIC)
-
Invested Capital
-
Stockholders Equity
-
Revenue Growth
-
Market Valuation
Market Cap
-
P/E Ratio
-
Price to Book
-
EPS (Diluted)
$1.40
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Insider Transactions
Neutral
Open Market Buys: -
Open Market Sales: -
Option Exercise & Sale: -
Net: -
Loading...
Loading insider transactions...
My Notes & Files
Personal Notes
Attached Files
Loading...
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address |
ONE CVS DR.
WOONSOCKET, RI 02895 |
| Phone | 4017651500 |
| Incorporated | DE, US |
| EIN | 050494040 |
| Fiscal Year End | 1231 |
| Stockholders' Equity | $75.21B |
| Cash & Equivalents | $8.45B |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-02
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-02
Local
13F-HR
13F-HR Filing
SEC regulatory filing
Filed: 2026-02-13
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-10
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-10
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-10-29
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-07-31
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-05-01
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-04-04
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-02-12
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-11-06
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-08-07
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-05-01
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2024-04-05
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2024-02-07
Local
Financial Statistics
Valuation
Market Cap
-
P/E Ratio (TTM)
-
Price to Book
-
EV/Revenue
-
EV/EBITDA
-
Profitability
Gross Margin
45.0%
Operating Margin
1.2%
Net Margin
0.4%
ROE
2.4%
ROA
0.7%
Leverage & Liquidity
Debt to Equity
2.37
Current Ratio
0.84
Total Debt
$60.50B
Total Assets
$253.54B
Stockholders' Equity
$75.21B
Income Statement (FY 2025)
Revenue
$402.07B
Gross Profit
$180.90B
Operating Income
$4.66B
Net Income
$1.77B
EPS (Diluted)
$1.40
Cash Flow (FY 2025)
Free Cash Flow
$16.72B
Cash & Equivalents
$8.45B
Revenue Growth
7.8%
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...